We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Smartphone Technology Meets Personalized Medicine

By HospiMedica International staff writers
Posted on 14 Mar 2012
An innovative smartphone electrocardiogram (ECG) system provides physicians and patients with hospital-quality heart rhythm monitoring outside of the hospital setting. More...


The CardioDefender Diagnostic System delivers mobile heart monitoring and automated reporting by combining patented analytical smartphone software with a Bluetooth device and electrodes, enabling the smartphone to perform as a mobile ECG. Among the features of the system are real-time, heart-rhythm monitoring, with beat-by-beat analysis; long term monitoring for up to three months of real-time, beat-by-beat quantitative patient monitoring; and a comprehensive range of heart rhythm monitoring algorithms that enable automated detection and reporting of medically important symptomatic and asymptomatic arrhythmias.

The abnormal heart rhythms are reported directly to the physician, using innovative software and data compression technology to report real-time results to a smartphone, tablets, laptop, or desktop computer, in addition to a cardiac monitoring center. Access is available on demand to full, detailed ECG data captured during the monitoring period, including post heart monitoring data processing for additional measurements. The CardioDefender Diagnostic System is a product of Everist Genomics (Ann Arbor, MI, USA), and has been approved by the US Food and Drug Administration (FDA).

“Physicians who diagnose and treat heart arrhythmias have been hampered for many years by legacy technology, such as hospital based ECG systems which confine patients to the high-cost hospital setting and Holter monitors which do not provide the comprehensive monitoring needed to detect potentially life threatening arrhythmias,” said Alex Charlton, executive vice chairman of Everist Genomics. “For the first time, CardioDefender enables smartphone-based hospital-quality ECG monitoring of patients 24 hours per day, seven days per week.”

In addition to the CardioDefender diagnostic system, the company has recently announced the development of the AngioDefender, a tablet computer device capable of accurately diagnosing atherosclerosis in asymptomatic patients.

Related Links:
Everist Genomics


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: Shutterstock

AI-Derived Heart Age Linked to Cardiovascular and Dementia-Related Mortality

Cardiovascular disease is increasingly associated with dementia-related mortality and other forms of age-related decline. Identifying people with greater long-term vulnerability before severe outcomes... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.